Abpro Holdings, Inc. (ABPO) stock
ABPOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ABPWW
$0.41+0.00 (+0.11%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Abpro net income
Net income is the profit left for shareholders after every expense, interest and tax.
Abpro's net income for the twelve months ending Jun 30, 2024 was -$78.72K, down 101.6% year over year. For fiscal 2023 it was $2.82M, up 218.1% from the year before.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $2.82M | +218.1% |
| FY2022 | Dec 31, 2022 | $886.92K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | -$3.89M | – |
| Q2 FY2024 | Jun 30, 2024 | -$338.85K | -142.2% |
| Q1 FY2024 | Mar 31, 2024 | $312.00K | -84.9% |
| Q4 FY2023 | Dec 31, 2023 | -$7.24K | -100.5% |
| Q3 FY2023 | Sep 30, 2023 | -$44.63K | -106.8% |
| Q2 FY2023 | Jun 30, 2023 | $802.80K | – |
| Q1 FY2023 | Mar 31, 2023 | $2.07M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.46M | – |
| Q3 FY2022 | Sep 30, 2022 | $652.42K | – |
| Q2 FY2022 | Jun 30, 2022 | -$196.92K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.00K | – |
See a number that looks wrong?